Search Results for "Immunotherapy"

Learn more about best practices for personal protective equipment during administration, compounding, and spill management of checkpoint inhibitors.  

Learn how oncolytic viruses work along with the proper preparation, administration, post-administration, as well as helpful tips for the safe handling of oncolytic viruses through this engaging infographic. 

Follow a nurse through assessment and early interventions to better understand cytokine release syndrome, an adverse reaction associated with Car T-Cell therapy.

Watch this ONS video on cytokine release syndrome with CAR T-cell therapy.

The Oncology Nursing Society’s Chemotherapy and Immunotherapy Guidelines and Recommendations for Practice (second edition) provides nurses with the tools to understand how medications are used in cancer treatment, the effect of medication-related toxicities, and evidence-based recommendations to manage and treat these toxicities.

None of the patients who were admitted for an immune checkpoint inhibitor (ICI)–related toxicity but received structured teaching at discharge were subsequently readmitted within 30 days, compared to nearly 50% of patients who did not receive teaching, ONS member Michelle L. Rohlfs, DNP, APRN, FNP-BC, AOCNP®, reported in study findings published in the Clinical Journal of Oncology Nursing.